New Angelman Research Collaborative Partnership Announcement The Canadian Angelman Syndrome Society (CASS) and Angelman Syndrome Foundation (ASF) today formally announce a collaborative research partnership to fund the Expert Panel on Challenging and Difficult to Treat Behaviors in Angelman Syndrome (AS). […]
Read moreAngelman Syndrome Foundation Funds More Than $1 Million in Research Grants for 2009 The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than […]
Read moreScientist Engineer Mice That Have Autism Researcher says other mouse models of disease exist, but this comes closer to mirroring disorder in humans. Read full article.
Read moreInsights For Autism From Angelman Syndrome By Benjamin Philpot, Angela Mabb, Matthew Judson Read the article.
Read moreNatural History Study and Drug Trial of Levodopa at Boston Children’s Hospital Angelman syndrome (AS) is a rare, neurogenetic condition characterized by severe developmental delay, movement disorder, speech impairment (often with a complete lack of speech) and an unusually happy […]
Read moreResearchers Use Stem Cells To Create Disease Models Researchers Use Stem Cells to Create Disease Models
Read moreLoss Of Enzyme Reduces Neural Activity In Angelman Syndrome New work from Michael Greenberg, chair of the department of neurobiology at Harvard Medical School (HMS), provides insight into the mystery by showing that the lost enzyme, Ube3A, interacts with a […]
Read more